What stage does NXT2B invest at?

NXT2B invests at the Seed, Series A, Series B, Growth stages.

What sectors does NXT2B focus on?

NXT2B focuses on Biotech, Consumer, Healthtech, Medical Devices.

Where is NXT2B located?

NXT2B is headquartered in Uppsala, SE.

NXT2B

Venture capital

Uppsala · Seed–Growth · 4 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

NXT2B is a fully privately owned venture capital firm that funds investments with its own capital, enabling fast decisions without reliance on external funding. It partners with competent, ambitious entrepreneurs and focuses on growth equity investments in healthcare, medical devices, and specialty pharmaceutical companies, while also backing technology and consumer companies with distinctive ideas. The firm targets early-phase projects of high scientific quality with reasonable commercial potential, committing to long-term relationships. NXT2B emphasizes active ownership, working alongside portfolio management teams to build market-leading companies, and draws on proven experience commercializing innovative projects.

Invests inBiotech Consumer Healthtech Medical DevicesEuropeSweden

Source: firm website, verified Aug 3, 2026.

Stage

Seed–Growth

Uppsala, SE

Instruments

Equity

Founded

2011

Tracked investments

Team · 4 people

from the firm's website & public directories

Erika Kjellberg Eriksson· CEO and Chair of the Board

Erika has over 20 years in the life science sector, previously serving as CFO of OxThera, VP and CFO of Q-Med, and CFO and CEO of BioPhausia. She holds a B.Sc. in Business and Economics from Uppsala University and began her career as an auditor at Ernst & Young.

e•••@nxt2b.comreveal

Angelica Loskog· Scientific adviser

Angelica is CEO of Lokon Pharma AB and a Professor of Immunotherapy at Uppsala University, working in immune, gene and cell therapy with a focus on cancer and autoimmune disease.

Bengt Ågerup· Senior Adviser

Swedish entrepreneur who founded NXT2B in 2011 and now serves as senior adviser. He previously held senior positions at Pharmacia and Biomatrix and founded Q-Med (maker of Restylane), later sold to Galderma. He has also served on the board of the Swedish Foundation for Strategic Research and chaired Stockholm Uppsala Life Science.

Per-Olof Wallström· Member of the Board

Per-Olof has 50 years of experience in the pharmaceutical and biotech industry, holding senior roles at Merck AB, Astra AB, Pharmacia AB and Bristol-Myers Squibb AB. He has served as CEO of Karo Bio AB, Melacure Therapeutics AB and Q-Med AB.

Investments · 9 tracked

founders shown can be your intro path

AllgoHolding AB

PartnerErika Kjellberg Eriksson· solo GP

Hansa Biopharma AB

PartnerErika Kjellberg Eriksson· solo GP

Lokon Pharma AB

PartnerErika Kjellberg Eriksson· solo GP

Lumina Adhesives AB

PartnerErika Kjellberg Eriksson· solo GP

Navinci Diagnostics AB

PartnerErika Kjellberg Eriksson· solo GP

Q-linea AB

PartnerErika Kjellberg Eriksson· solo GP

Repos Pharma AB

PartnerErika Kjellberg Eriksson· solo GP

Scint-X AB

PartnerErika Kjellberg Eriksson· solo GP

Vivolux AB

PartnerErika Kjellberg Eriksson· solo GP

Frequently asked questions

What stage does NXT2B invest at?: NXT2B invests at the Seed, Series A, Series B, Growth stages.
What sectors does NXT2B focus on?: NXT2B focuses on Biotech, Consumer, Healthtech, Medical Devices.
Where is NXT2B located?: NXT2B is headquartered in Uppsala, SE.

Similar investors

ACT Venture Capital

ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.

$1.1M – $16.2M

Amadeus Capital Partners

Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.

$50K – $12.7M

EDB Investments

EDBI is the investment platform of Singapore's Economic Development Board and Enterprise Singapore, focusing on high-growth technology companies expanding into Singapore and Asia.

$12M – $400M

Khosla Ventures

Khosla Ventures is a venture capital firm known for backing bold, contrarian bets in world-class teams that can reshape entire industries.

$5K – $50M

Kleiner Perkins

Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, with a portfolio of companies from early stage through growth.

$500K – $15M